Europe To Review Validity Of Key Nexium Patent
The European Patent Office plans to take a closer look at AstraZeneca PLC's control of its blockbuster heartburn drug Nexium in an appeals case over the drug's patent....To view the full article, register now.
Already a subscriber? Click here to view full article